NEGG does not currently have a usable analyst price-target consensus. MarketBeat lists no active consensus price target, and the only recent rating action is a reiterated Sell from Weiss Ratings (October 2026), which carries no usable price objective. Older figures, including a $60 target listed by MarketWatch and a $70 target from Noble Financial dating to 2023, are stale and are excluded here. The data error occasionally cited in third-party aggregators (a low target of $10,000,000) is also disregarded.
Because credible current targets are absent, the $15 objective is drawn from public valuation discussion rather than analyst consensus. A 12-month research estimate from Mavefund pointed to roughly $15, a GuruFocus discounted cash flow (DCF) model implied a fair value near $14, and Simply Wall St's cash-flow model suggested a value near $18.50 while also flagging the shares as potentially overvalued relative to its own assumptions. These independent, valuation-based references form the basis of a $15 discussion target. I also checked this using Tickeron’s AI Daily Buy/Sell Signals to gauge momentum shifts.
NEGG closed near $9.89 on October 27, 2026, with after-hours trading near $10.04 and a market capitalization of roughly $207 million. The 52-week range spans roughly $9.29 to $96.29, meaning the stock trades near the low end of a historically volatile band. Reaching $15 from $9.89 requires an increase of about 52%, which is a very large move for any stock and especially demanding for a thinly traded micro-cap.
The path would likely depend on stabilizing revenue, expanding the B2B segment, and rebuilding investor confidence after governance concerns. Recent financial data indicate net sales declined roughly 8% year over year to about $320 million, while net income was modestly positive. A sustained return to revenue growth and profitability would be central to any move toward $15.
The most durable reference points are the 52-week low near $9.29 and the 52-week high near $96.29. The stock trades just above its multi-year low, with the $10 round-number level acting as a psychological threshold that has been tested recently. On the upside, any recovery would need to reclaim prior trading zones well above current levels before $15 becomes visible. Elevated daily volatility, reported near 9% at times, means these levels can shift quickly.
The $15 figure reflects a roughly 12-month valuation horizon from public research estimates, though no single authoritative timeframe applies. Investors should monitor quarterly revenue trends, B2B segment growth, gross margin, any resolution or escalation of the governance investigation, analyst rating changes, and overall consumer electronics demand. Because the stock is high-beta and thinly traded, sentiment and technical behavior can matter as much as fundamentals in the near term.
NEGG reaching $15 would require a very large move of about 52% from its recent price near $9.89. The $15 level is grounded in public valuation estimates rather than analyst consensus, since the stock lacks current, credible sell-side price targets. The strongest supports are the B2B pivot and a return to modest profitability, while the principal obstacles are falling revenue, governance uncertainty, thin liquidity, and extreme volatility. With no meaningful bullish analyst coverage and a wide historical trading range, the $15 objective represents a meaningful recovery scenario rather than a baseline expectation. Investors should watch revenue stabilization and B2B traction before drawing conclusions about the stock's direction.
In my own work, Tickeron’s AI Daily Buy/Sell Signals provide a useful layer for tracking stocks like this. The platform applies artificial intelligence to monitor market conditions, technical behavior, and other factors across thousands of names, helping surface potential shifts in momentum more efficiently. For volatile micro-caps, that kind of ongoing, data-driven input can complement traditional analysis without replacing it.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
The RSI Oscillator for NEGG moved out of oversold territory on October 27, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 49 similar instances when the indicator left oversold territory. In 42 of the 49 cases the stock moved higher. This puts the odds of a move higher at 86%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
NEGG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Moving Average Convergence Divergence Histogram (MACD) for NEGG turned negative on October 22, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In 36 of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NEGG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for NEGG entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 60 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.212) is normal, around the industry mean (22.666). P/E Ratio (21.850) is within average values for comparable stocks, (9.403). Projected Growth (PEG Ratio) (0.270) is also within normal values, averaging (1.774). Dividend Yield (0.000) settles around the average of (0.033) among similar stocks. P/S Ratio (0.202) is also within normal values, averaging (1.321).
The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. NEGG’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NEGG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of medical equipment including sleep apnea machines, patient monitors, air compressors and oxygen generators
Industry InternetRetail